In summary, our data suggest that UCP2 deficiency enhances NLRP3 inflammasome activation and ROS production after neurons in hyperglycemia-exacerbated cerebral I/R damage in vivo and in vitro. Here, NLRP3 is linked to Hyperglycemia.